Document is current

Any future updates will be listed below

Correction: Predictive progression outcomes and risk stratification in patients with recurrent or metastatic nasopharyngeal carcinoma who received first‑line immunochemotherapy

Crossref DOI link: https://doi.org/10.1007/s12094-024-03389-5

Published Online: 2024-02-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark